[Pr]Trends in Neurology at Osaka University from the Tekitekisaijuku
Hideki Mochizuki(Department of Neurology, Osaka University Graduate School of Medicine, Japan)
Search Criteria
Keywords :
Year :
2018 - 2025
Search across all events. Up to 10,000 search results will be displayed.
-
Search Criteria
| Keywords : | |
|---|---|
| Year : | 2018 - 2025 |
Search across all events. Up to 10,000 search results will be displayed.
-
Search Results(10,000+)
Due to the large number of search results, only up to 10,000 are displayed. If you cannot find the results you need, please refine your search by specifying additional conditions.
[PL-01-1]Future Therapy for Parkinson's Disease. The role of Blood Brain Barrier Opening
José A. Obeso1,2,3(1.HM-CINAC, Fundación HM Hospitales and HM Puerta del Sur Hospital, Spain, 2.Universidad CEU-San Pablo, Spain, 3.CIBERNED, Instituto Carlos III, Spain)
[PL-02-1]Regulatory T cells for treatment of immunological diseases
Shimon Sakaguchi(Immunology Frontier Research Center, Osaka University, Japan)
[PL-03-1]Recent advances in clinical trials for the treatment of Parkinson disease
Olivier Rascol1,2,3(1.Neurosciences and Clinical Pharmacology at Toulouse University Hospital, France, 2.Clinical Pharmacology at University of Toulouse, France, 3.Clinical Investigation Center INSERM, France)
[PL-04-1]My disease-oriented research and patient-oriented research as a physician scientist
Takashi Kadowaki1,2(1.President, Toranomon Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Japan, 2.President, The Japanese Association of Medical Sciences／The Japanese Medical Science Federation, Japan)
[AW-1]Elucidating Pathomechanisms and Developing Biomarkers of Parkinson's Disease
Taku Hatano(Department of Neurology, Juntendo University Faculty of Medicine, Japan)
[AW-2]Comprehensive education of epilepsy & EEG aiming for improved epilepsy care by neurologists in Japan
Akio Ikeda(Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine, Japan)
[HQ-01-1]Jean-Martin Charcot (1825-1893), Founder of clinical neurology
Makoto Iwata(Medical Clinic Kakinokizaka, Japan)
[HQ-01-2]Lessons of Charcot's Neurophotography
Mitsuru Kawamura(Showa Medical University, Japan)
[HQ-01-3]Charcot and his herald Duchenne
Masaaki Konagaya(National Hospital Organization Suzuka Hospital, Japan)
[HQ-01-4]Did Charcot influence Sherlock Holmes? - Neurodiagnostics and Detective Studies -
Toshio Fukutake(Department of Neurology, Kameda Neurocenter, Kameda Medical Center, Japan)
[HQ-01-5]The Master-Disciple Relationship Between Miura Kinnosuke and Jean-Martin Charcot
Takayoshi Shimohata1, Makoto Iwata2(1.Department of Neurology, Gifu University Graduate School of Medicine, Japan, 2.Medical Clinic Kakinokizaka, Japan)
[HQ-02-1]Dr. Koan Ogata
Taroh Kinoshita(Center for Infectious Disease Education and Research, Osaka University, Japan)
[HQ-02-2]Koan Ogata, C.J.Ermerins, and the Beginnings of Neurology
Hideki Mochizuki(Department of Neurology, Osaka University Graduate School of Medicine, Japan)
[HQ-02-3]Prof. Kitou Onishi, Prof. Toyotane Wada and neurology
Masatoshi Takeda(President, Osaka Kawasaki Rehabilitation University, Japan)
[HQ-02-4]Dr. Isamu Sano and Parkinson's Disease
Akira Sano(Kagoshima University, Japan)
[HQ-02-5]Dr Seiichiro Tarui and Tarui Disease
Takanori Hazama(Osaka Minami Medical Center, Japan)
[HQ-02-6]Tadaatsu Nukada and Angiologly/Stroke group in the first department of Medicine, Osaka University
Kazuo Kitagawa(Suita Municipal Hospital, Japan)
[HQ-02-7]Dr. Takehiko Yanagihara and Neurology of Mayo Clinic
Toshiki Yoshimine(Iseikai Medical Corporation, Japan)
[HQ-02-8]Dr. Sakoda and Neurology
Yuji Nakatsuji(Department of Neurology, Toyama University Hospital, Japan)
[HQ-03-1]Accelerating the Patient-Centered Genomic Medicine
Yasuhisa Shiozaki(Keisou Nippon Initiative Foundation, Japan)
[HQ-03-2]Undiagnosed disease and single gene disease
Hidehiro Mizusawa1,2(1.National Center of Neurology and Psychiatry, Japan, 2.Institute of Science Tokyo, Japan)
[HQ-03-3]History and Future of Genomic Research in Multifactorial Diseases
Noriko Isobe(Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Japan)
[HQ-03-4]Future directions of medical genomics
Shoji Tsuji(Institute of Medical Genomics, International University of Health and Welfare, Japan)
[NFS-01-1]GGC repeat expansions in ZFHX3 cause SCA4
Andreas Puschmann1,2(1.Dept. of Neurology, Lund University, Sweden, 2.Dept. of Neurology, Skåne University Hospital, Sweden)
[NFS-01-2]Pathogenesis of RFC1 repeat expansions disorder
Fumiaki Tanaka, Hiroshi Doi(Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan)
[NFS-01-3]High-Resolution Repeat Analysis of SCA27B with Nanopore Sequencing: A Step Forward in Neurogenetics
Satoko Miyatake(Department of Clinical Genetics, Yokohama City University Hospital, Japan)
[NFS-01-4]Molecular mechanisms of RAN translation and neurodegeneration in SCA36
Yoshitaka Nagai1,2(1.Department of Neurology, Kindai University Faculty of Medicine, Japan, 2.Life Science Research Institute, Kindai University, Japan)
[NFS-02-1]Progress of Heteroduplex oligonucleotide (HDO) to muscle and CNS
Takanori Yokota(Department of Neurology and Neurological Science, Institute of Science Tokyo, Japan)
[NFS-02-2]Silencing FUS and Other Rare Genetic Forms of ALS
Neil A. Shneider(Columbia University, USA)
[NFS-02-3]Microglia replacement for neurological disease therapy
Schuichi Koizumi1,2(1.Dept Neuropharmacol, Grad Sch Med, Univ Yamanashi, Japan, 2.Yamanashi GLIA Center, Japan)
[NFS-02-4]Stem cell gene therapy for brain tumor
Masahiro Toda(Department of Neurosurgery, Keio University School of Medicine, Japan)
[NFS-02-5]iPSC-based therapy for Parkinson's disease
Jun Takahashi(Center for iPS cell research and application (CiRA), Kyoto University, Japan)
[NFS-03-1]Research priorities to understand the role of alpha-Synuclein in Parkinson's disease
Stella M. Papa(Emory University, USA)
[NFS-03-2]Molecular mechanisms of Parkinson's disease: from classification to treatment
Tiago F. Outeiro1,2(1.University Medical Center Goettingen, Germany, 2.Newcastle University, UK)
[NFS-03-3]Alpha-synuclein as a blood biomarker
Ayami Okuzumi, Taku Hatano, Nobutaka Hattori(Department of Neurology, Faculty of Medicine, Juntendo University, Japan)
[NFS-03-4]Elucidating the pathogenesis of alpha-synucleinopathy using human brain single nucleus RNAseq
Kotaro Ogawa(Department of Neurology, Osaka University Graduate School of Medicine, Japan)
[HT-01-1]Epilepsy classification: The 2017 update and its clinical implications
Yuichiro Shirota(Department of Clinical Laboratory, the University of Tokyo Hospital, Japan)
[HT-01-2]Epileptic syndrome -overview-
Hideaki Shiraishi(Department of Pediatrics, Dokkyo Medical University, Japan)
[HT-01-3]Genes associated with epilepsy syndrome
Hiroyuki Ishiura(Department of Neurology, Okayama University, Japan)
[HT-01-4]Epilepsy treatment algorithm
Akihiro Shimotake(Department of Neurology and Clinical Research Center, NHO Utano National Hospital, Japan)
[HT-02-1]Autoimmune encephalitis and NMOSD: translational immunological findings
Sarosh R. Irani(Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA)
[HT-02-2]Autoimmune encephalitis and its related disorders in Taiwan: update 2025
Mei-Yun Cheng(Chang Gung Memorial Hospital Linkou Medical Center and Chang Gung University College of Medicine, Taiwan)
[HT-02-3]MOG antibody associated disease in Japan: update 2025
Ichiro Nakashima(Division of Neurology, Tohoku Medical and Pharmaceutical University, Japan)
[HT-02-4]Anti-NMDAR/anti-LGI1 encephalitis in Japan: update 2025
Izumi Kawachi1,2(1.Department of Neurology, Brain Research Institute, Niigata University, Japan, 2.Medical Education Center, Niigata University School of Medicine, Japan)
[HT-03-1]Current situation and issues of Drug Loss and government efforts to solve them
Daisuke Sato(Pharmaceutical Evaluation Division, Pharmaceutical Safety Bureau, Ministry of Health, Lanour and Welfare, Japan)
[HT-03-2]The Current Situation of Drug Loss in Japan from the Perspective of the Pharmaceutical Industry
Toshiharu Sano(Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee, Japan)
[HT-03-3]Drug Loss in Stroke: Current Status and Solutions
Haruko Yamamoto(National Cerebral and Cardiovascular Center, Japan)
[HT-03-4]Current Status of Drug Loss and Approaches in Amyotrophic Lateral Sclerosis
Ken Sakushima(Institute of Health Science Innovation for Medical Care, Hokkaido University Hospital, Japan)
[HT-03-5]Current Challenges and Solutions for Drug Loss in Duchenne Muscular Dystrophy
Yoshitsugu Aoki(Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan)
10,000 results ( 1 - 50 )
- 1
- ...